Markets.com Logo

NBY

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.9461$
  • Previous Close
    1.0604$
  • 52 Week Change
    0.81$
  • Day Range
    -0.11$
  • 52 Week High/Low
    0.44$ - 1.25$
  • Dividend Per Share
    --
  • Market cap
    6 223 K$
  • EPS
    -0.34
  • Beta
    0.405
  • Volume
    --

About

Newbury Street Acquisition Corporation (NBY.US) was a special purpose acquisition company (SPAC). SPACs are shell corporations listed on a stock exchange with the purpose of acquiring a private company, thus making it public without the traditional initial public offering process. Newbury Street Acquisition Corporation ultimately completed a business combination with Infinite Reality, Inc. and ceased trading under the NBY.US ticker symbol. As such, NBY.US is no longer an active financial product.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Financial Performance: NBY.US's revenue, profitability, and earnings per share significantly influence investor confidence and stock valuation.

Industry Trends: Broader trends in the biotechnology or pharmaceutical industry, including regulatory changes and competition, impact NBY.US's outlook.

Clinical Trial Results: The success or failure of NBY.US's clinical trials for new drugs is a major driver of stock price fluctuations.

Regulatory Approvals: FDA or other regulatory approvals for NBY.US's products are crucial for commercialization and affect investor sentiment.

Market Sentiment: General market conditions, investor risk appetite, and overall sentiment towards biotech stocks play a role.

Company News: Announcements about partnerships, acquisitions, or new product developments can influence NBY.US's stock price.

Economic Conditions: Macroeconomic factors such as interest rates, inflation, and economic growth can affect overall market valuations.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--